Chemoradiotherapy with 3-weekly CDDP 80â
mg/m2 for head and neck squamous cell carcinoma: 5-year survival data from a phase 2 study.
Front Surg
; 9: 1035349, 2022.
Article
in En
| MEDLINE
| ID: mdl-36589621
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Risk_factors_studies
Language:
En
Journal:
Front Surg
Year:
2022
Type:
Article
Affiliation country:
Japan